LUNDBECK PHARMA A/S
56750215ActiveGlobal pharmaceutical company dedicated to advancing treatments for brain diseases.
Publicly traded pharmaceutical companylundbeck.com
Yleiskatsaus
- 19
- Työntekijät
- Tuntematon
- Liikevaihto
- 1958
- Perustettu
Avainpäättäjät
Klaus Simonsen
Vice President, Head of External Research & Innovation
@lundbeck.com
Karin Hamberg
Chief Medical Officer
@lundbeck.com
Tarek Samad
Senior Vice President & Global Head of Research, Corporate Patents & Trademarks
@lundbeck.com
Dorothea Wenzel
Chair of the Board
@lundbeck.com
+6 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Lundbeck is a global pharmaceutical company that specializes exclusively in the research, development, and commercialization of treatments for brain diseases. With over 70 years of neuroscience expertise, the company focuses on conditions such as depression, schizophrenia, Parkinson's disease, and m...